Literature DB >> 33633339

Leukocyte related parameters in older adults with metabolically healthy and unhealthy overweight or obesity.

Shan-Shan Zhang1, Xue-Jiao Yang1, Qing-Hua Ma2, Yong Xu1, Xing Chen3, Pei Wang4,5, Chen-Wei Pan6.   

Abstract

It remains unclear whether leukocyte-related parameters could be used as biomarkers to differentiate metabolically unhealthy overweight/obesity (MUO) from metabolically healthy overweight/obesity (MHO). We aimed to examine the differences in the distribution of leukocyte-related parameters between older adults with MHO and MUO and the correlations of leukocyte-related parameters with individual components of metabolic abnormality. In the Weitang Geriatric Diseases Study on older Chinese adults aged 60 years or above, 404 individuals with MHO and 480 with MUO contributed to the analysis. Overweight/obesity was defined as body mass index (BMI) of 25 kg/m2 or more. MHO and MUO were discriminated based on the Adult Treatment Panel III (ATP III) criteria. Leukocyte-related parameters were assessed using an automated hematology analyzer. All leukocyte-related parameters except monocytes were elevated in MUO group compared with MHO group (all P < 0.05). The prevalence of MUO increased by 24% with each 109/L increase of leukocytes after adjusting for confounders in the multiple-adjusted model (P < 0.01) and each unit elevation of other parameters except lymphocytes and monocytes were significantly associated with the presence of MUO (all P < 0.01). Trend tests revealed a linear trend for the association between MUO and all the leukocyte-related parameters (all P for trend < 0.05). Significant interactions between leukocyte-related parameters and sex on the presence of MUO were observed (all P value for interaction < 0.05). Higher leukocyte-related parameters were found in patients with MUO than those with MHO and were associated with higher prevalence of MUO which seems to be sex-dependent. Further studies are needed to see whether these parameters could be used as biomarkers for the screening or diagnosis for MUO in clinical or public health practice.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33633339      PMCID: PMC7907258          DOI: 10.1038/s41598-021-84367-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  40 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils.

Authors:  Maho Suzukawa; Hiroyuki Nagase; Ikuko Ogahara; Kaiyu Han; Hiroyuki Tashimo; Akiko Shibui; Rikiya Koketsu; Susumu Nakae; Masao Yamaguchi; Ken Ohta
Journal:  J Immunol       Date:  2011-03-18       Impact factor: 5.422

3.  Metabolic alterations in morbid obesity. Influence on the haemorheological profile.

Authors:  Amparo Vayá; Antonio Hernández-Mijares; Marta Suescun; Eva Solá; Rosa Cámara; Marco Romagnoli; Daniel Bautista; Begoña Laiz
Journal:  Clin Hemorheol Microcirc       Date:  2011       Impact factor: 2.375

4.  Body size phenotypes and inflammation in the Women's Health Initiative Observational Study.

Authors:  Rachel P Wildman; Robert Kaplan; JoAnn E Manson; Aleksandar Rajkovic; Stephanie A Connelly; Rachel H Mackey; Lesley F Tinker; J David Curb; Charles B Eaton; Sylvia Wassertheil-Smoller
Journal:  Obesity (Silver Spring)       Date:  2011-01-13       Impact factor: 5.002

5.  Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.

Authors:  Matina Kouvari; Demosthenes B Panagiotakos; Mary Yannakoulia; Ekavi Georgousopoulou; Elena Critselis; Christina Chrysohoou; Dimitrios Tousoulis; Christos Pitsavos
Journal:  Metabolism       Date:  2019-01-11       Impact factor: 8.694

Review 6.  Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.

Authors:  Andreja Trpkovic; Ivana Resanovic; Julijana Stanimirovic; Djordje Radak; Shaker A Mousa; Desanka Cenic-Milosevic; Danimir Jevremovic; Esma R Isenovic
Journal:  Crit Rev Clin Lab Sci       Date:  2014-12-24       Impact factor: 6.250

7.  Prevalence and cardiometabolic risks of normal weight obesity in Chinese population: A nationwide study.

Authors:  A Jia; S Xu; Y Xing; W Zhang; X Yu; Y Zhao; J Ming; Q Ji
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-06-25       Impact factor: 4.222

Review 8.  Metabolically healthy versus metabolically unhealthy obesity.

Authors:  Carla Iacobini; Giuseppe Pugliese; Claudia Blasetti Fantauzzi; Massimo Federici; Stefano Menini
Journal:  Metabolism       Date:  2018-11-17       Impact factor: 8.694

9.  Hematologic parameters as the predictors for metabolic syndrome in perimenopausal and postmenopausal women living in urban area: a preliminary report.

Authors:  Patsama Vichinsartvichai; Siriwan Sirirat
Journal:  Prz Menopauzalny       Date:  2016-07-22

10.  Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals.

Authors:  Xiao-Li Wang; Xiang-Yun Chang; Xiao-Xiao Tang; Zhi-Gang Chen; Ting Zhou; Kan Sun
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

View more
  1 in total

Review 1.  The Immune Response in Adipocytes and Their Susceptibility to Infection: A Possible Relationship with Infectobesity.

Authors:  Orestes López-Ortega; Nidia Carolina Moreno-Corona; Victor Javier Cruz-Holguin; Luis Didier Garcia-Gonzalez; Addy Cecilia Helguera-Repetto; Mirza Romero-Valdovinos; Haruki Arevalo-Romero; Leticia Cedillo-Barron; Moisés León-Juárez
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.